Many companies have CEOs, CFOs, and COOs, but for them to have also chief AI officers is equally important nowadays. This is true above all because most companies report they have not yet been able to fully exploit the benefits of AI. Tech writer Priya Dialani elaborates.

AI and associated technologies are taking the drug discovery sector by storm by shifting it into warp drive. Technology writer Priya Dialani, host of The Yuan’s Delta Dialog podcast, showcases inspiring examples of intrepid pioneers applying AI and supercharging drug development.

Through their cutting-edge AI solutions, businesses are transforming healthcare in the EU. Advanced algorithms are increasing patient outcomes, diagnostic efficiency and accuracy, and the analysis of medical imaging. To learn more about the impact of AI on healthcare and the future of radiology, listen to the entire episode.

Voice-assisted AI has revolutionized customer-business interactions, but there is potential for further development in the field. Overcoming challenges is necessary to capitalize on untapped opportunities and meet customer demands

Data science unlocks data’s value to enable decision-making that transforms healthcare, finance, agriculture, and transport. Its models confer competitiveness and drive vast demand for data scientists. Burgeoning data fuel the need for data science as a huge development catalyst.

Virtual and augmented reality were once mostly confined to gaming, entertainment, and science-fiction flicks but they have now moved beyond into healthcare. ThirdEye is one company at the forefront of use of these technologies to achieve better healthcare and patient experiences.

As the field of artificial intelligence continues to rapidly advance, there is growing interest in its potential applications to drug development. With the ability to process vast amounts of data and make complex predictions, AI has the potential to greatly accelerate the drug discovery process, leading to more efficient and effective treatments for a range of diseases. However, there are also important ethical and regulatory considerations that must be taken into account when using AI in drug development.

India has long been a hub of pharmaceutical development and production and many Indian startups in this domain have lately turned to technology - especially AI and ML - to cut the time, cost, and effort needed to develop new drugs and gain approval for their use, which formerly took many years.

AI expert and entrepreneur Priya Dialani relates to The Yuan how Fujitsu Research is making healthcare more effective with AI, especially in cancer treatments. Genomic medicine and therapies - AI-driven individualized treatments based on individuals’ unique genomic sequences - also hold huge potential for breakthroughs.

The Government of India is pushing various initiatives to turn the country into a haven of healthcare AI, but entrepreneur and The Yuan contributor Priya Dialani questions when this resolve will actually transform into reality.

Priya Dialani maps India’s mental health terrain and discusses how artificial intelligence is breaking through traditional taboos to deliver care to those most in need in the second-most populous country.

Virtual reality and augmented reality are bringing whole new worlds into being. Priya Dialani discusses their present and future applications in healthcare.

Priya Dialani believes women are being left behind as the Fourth Industrial Revolution gathers momentum, but has confidence, thanks to the advent of digitization, that digital health leaders can transform the landscape of women’s health by empowering women to take control of their wellbeing as well as supplanting commonly held misconceptions and taboos.

It is hard to believe artificial intelligence still has dissenting voices despite the great leaps forward, increased productivity, and efficiency that allows healthcare systems to provide better care for more people. Priya Dialani locks horns with those dissenters and debunks the crucial myths creating a bubble of skepticism around AI.

The novel coronavirus created global havoc. Governments and hospitals were inundated with an influx of patients. One of the challenges is managing resources - both human and material, as resources are limited and can be rapidly consumed. Hence, in order to facilitate better allocation and avoid wastage of resources, artificial intelligence was at the rescue. Here's how AI can ensure better resource management in any given pandemic.

India gained its “Pharmacy of the World” title because of its significant role in providing high-quality, yet cost-effective drugs across the world. And the drug industry continued to do well last year despite the Covid-19 pandemic, bolstered by structural cost advantages, adopting innovative and tech-driven approaches in manufacturing.

AI-driven solutions have been leveraged to detect high-risk Covid-19 patients at an early stage. This has helped in curbing the spread of the virus in real-time. It also means that patients don’t have to go to hospitals or clinics for diagnosis. It is a cost and time-effective solution, helping the healthcare community to serve a larger population during a pandemic.

The unsavory truth is that countries across the globe do not have a smart, effective framework to help people get vaccinated. AI is the unique toolkit that is needed to speed up the Covid-19 vaccine rollout in most nations.